Literature DB >> 28634787

Insulin resistance in ischemic stroke.

Xiao-Ling Deng1, Zhou Liu2, Chuanling Wang3, Yanfeng Li4, Zhiyou Cai5.   

Abstract

Insulin resistance often refers to a pathological condition in which cells fail to respond to the normal actions of insulin. Increasing literature has noted a critical role of insulin resistance in the pathogenesis of ischemic stroke. Insulin resistance plays an important role in the pathogenesis of ischemic stroke via enhancing advanced changes of atherosclerosis. A variety of literature indicates that insulin resistance enhances platelet adhesion, activation and aggregation which are conducive to the occurrence of ischemic stroke. Insulin resistance also induces hemodynamic disturbances and contributes to the onset of ischemic stroke. In addition, insulin resistance may augment the role of the modifiable risk factors in ischemic stroke and induce the occurrence of ischemic stroke. Preclinical and clinical studies have supported that improving insulin resistance may be an effective measure to prevent or delay ischemic stroke.

Entities:  

Keywords:  Atherosclerosis; Insulin resistance; Ischemic stroke; Risk factor

Mesh:

Year:  2017        PMID: 28634787     DOI: 10.1007/s11011-017-0050-0

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  181 in total

Review 1.  Dyslipidaemias, insulin resistance and atherosclerosis.

Authors:  M Laakso
Journal:  Ann Med       Date:  1992-12       Impact factor: 4.709

2.  Comparison between indexes of insulin resistance for risk prediction of cardiovascular diseases or development of diabetes.

Authors:  Björn Zethelius; Jan Cederholm
Journal:  Diabetes Res Clin Pract       Date:  2015-09-18       Impact factor: 5.602

Review 3.  The metabolic syndrome as a risk factor for venous and arterial thrombosis.

Authors:  Francesco Dentali; Alessandro Squizzato; Walter Ageno
Journal:  Semin Thromb Hemost       Date:  2009-09-08       Impact factor: 4.180

4.  Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis.

Authors:  S J Yang; S Y Hwang; H Y Choi; H J Yoo; J A Seo; S G Kim; N H Kim; S H Baik; D S Choi; K M Choi
Journal:  J Clin Endocrinol Metab       Date:  2011-06-15       Impact factor: 5.958

Review 5.  Thiazolidinediones in the treatment of insulin resistance and type II diabetes.

Authors:  A R Saltiel; J M Olefsky
Journal:  Diabetes       Date:  1996-12       Impact factor: 9.461

6.  The impairment of IGF-I-stimulated protein synthesis and activation of protein kinase B, p70(S6k), MAP kinase, and p90(rsk) in mouse C2C12 myogenic cells exposed to high glucose and high insulin.

Authors:  K Grzelkowska-Kowalczyk; W Wieteska
Journal:  Pol J Vet Sci       Date:  2005       Impact factor: 0.821

Review 7.  Insulin resistance, hyperglycemia, and atherosclerosis.

Authors:  Karin E Bornfeldt; Ira Tabas
Journal:  Cell Metab       Date:  2011-11-02       Impact factor: 27.287

8.  Insulin resistance negatively affects long-term outcome in non-diabetic patients with coronary artery disease after therapies to reduce atherosclerotic risk factors.

Authors:  Yoshinobu Kitta; Takamitsu Nakamura; Manabu Uematsu; Wataru Sugamata; Juntarou Deyama; Daisuke Fujioka; Yukio Saito; Kenichi Kawabata; Jun-ei Obata; Kiyotaka Kugiyama
Journal:  J Cardiol       Date:  2013-07-01       Impact factor: 3.159

9.  Role of Hypoxia Inducible Factor 1 in Hyperglycemia-Exacerbated Blood-Brain Barrier Disruption in Ischemic Stroke.

Authors:  Ziyan Zhang; Jingqi Yan; Honglian Shi
Journal:  Neurobiol Dis       Date:  2016-07-16       Impact factor: 5.996

10.  Insulin resistance is an important risk factor for cognitive impairment in elderly patients with primary hypertension.

Authors:  Lina Ma; Ming Feng; Yuying Qian; Wei Yang; Jia Liu; Rui Han; Hong Zhu; Yun Li
Journal:  Yonsei Med J       Date:  2015-01       Impact factor: 2.759

View more
  17 in total

Review 1.  Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role.

Authors:  Richa Tyagi; Bhupesh Vaidya; Shyam Sunder Sharma
Journal:  Pharmacol Rep       Date:  2022-09-23       Impact factor: 3.919

2.  Serum, Dietary, and Supplemental Vitamin D Levels and Insulin Resistance in 6294 Randomly Selected, Non-Diabetic U.S. Adults.

Authors:  Larry A Tucker
Journal:  Nutrients       Date:  2022-04-28       Impact factor: 6.706

3.  Interleukin-13 ameliorates postischemic hepatic gluconeogenesis and hyperglycemia in rat model of stroke.

Authors:  Keng-Ying Liao; Chun-Jung Chen; Sheng-Kuo Hsieh; Ping-Ho Pan; Wen-Ying Chen
Journal:  Metab Brain Dis       Date:  2020-07-06       Impact factor: 3.584

4.  Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort study.

Authors:  Chi-Hung Liu; Pi-Shan Sung; Yan-Rong Li; Wen-Kuan Huang; Tay-Wey Lee; Chin-Chang Huang; Tsong-Hai Lee; Tien-Hsing Chen; Yi-Chia Wei
Journal:  PLoS Med       Date:  2021-07-19       Impact factor: 11.069

Review 5.  Cardio-Metabolic Benefits of Plant-Based Diets.

Authors:  Hana Kahleova; Susan Levin; Neal Barnard
Journal:  Nutrients       Date:  2017-08-09       Impact factor: 5.717

6.  iPSC-derived familial Alzheimer's PSEN2 N141I cholinergic neurons exhibit mutation-dependent molecular pathology corrected by insulin signaling.

Authors:  Cesar L Moreno; Lucio Della Guardia; Valeria Shnyder; Maitane Ortiz-Virumbrales; Ilya Kruglikov; Bin Zhang; Eric E Schadt; Rudolph E Tanzi; Scott Noggle; Christoph Buettner; Sam Gandy
Journal:  Mol Neurodegener       Date:  2018-06-26       Impact factor: 14.195

7.  Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study.

Authors:  Chi-Hung Liu; Tsong-Hai Lee; Yu-Sheng Lin; Pi-Shan Sung; Yi-Chia Wei; Yan-Rong Li
Journal:  Cardiovasc Diabetol       Date:  2020-01-07       Impact factor: 9.951

8.  Triglyceride-glucose index and the risk of stroke and its subtypes in the general population: an 11-year follow-up.

Authors:  Anxin Wang; Guangyao Wang; Qian Liu; Yingting Zuo; Shuohua Chen; Boni Tao; Xue Tian; Penglian Wang; Xia Meng; Shouling Wu; Yongjun Wang; Yilong Wang
Journal:  Cardiovasc Diabetol       Date:  2021-02-18       Impact factor: 9.951

9.  Fasting glucose and HbA1c levels as risk factors for the presence of intracranial atherosclerotic stenosis.

Authors:  Yan-Li Wang; Xin-Yi Leng; Yi Dong; Xiao-He Hou; Lin Tong; Ya-Hui Ma; Wei Xu; Mei Cui; Qiang Dong; Lan Tan; Jin-Tai Yu
Journal:  Ann Transl Med       Date:  2019-12

10.  Serum Matrix Metalloproteinase 9 and Macrophage Migration Inhibitory Factor (MIF) Are Increased in Young Healthy Nonobese Subjects with Positive Family History of Type 2 Diabetes.

Authors:  Agnieszka Nikołajuk; Natalia Matulewicz; Magdalena Stefanowicz; Monika Karczewska-Kupczewska
Journal:  Int J Endocrinol       Date:  2018-09-13       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.